John Poulos

Mr. John Poulos (b. 1954) has a wealth of expertise in global corporate life sciences, having spent 38 years working for AbbVie and Abbott. He served as Vice President, Head of Business Development and Acquisitions for AbbVie from 2013 until 2016. He was also Group Vice President, Head of Pharmaceutical Licensing and Acquisitions for Abbott from 2005 until 2012. During his career with AbbVie and Abbott, Mr Poulos was instrumental in the negotiation of numerous acquisitions, including Knoll/BASF Pharma in

2001 for $6.9 billion, Kos Pharmaceuticals in 2006 for $3.7 billion, Solvay in 2010 for $6.2 billion and Pharmacyclics in

2015 for $21 billion.

Mr. Poulos is currently President GNK Advisors Inc., a Pharmaceutical Business Development firm, and is a

member of the Board of Memgen.

He was appointed to the Board as a Non-Executive Director in May 2017.